Mach7 Technologies (ASX:M7T) appoint a new director

29DecDecember 29, 2020

Mach7 Technologies (ASX:M7T) appoint a new director

Data management solutions company Mach7 Technologies (ASX:M7T) has appointed Philippe Houssiau as a Non-Executive Director, effective from 1 January 2021.

Philippe has held a variety of executive and board member roles for Healthcare IT companies across the globe.

His experience as a small company owner, consultancy partner, entrepreneur, CEO and chairman will bring a depth of experience that will assist the Company in executing significant strategic, financial, and operational outcomes.

Philippe is based in Antwerp in Belgium.

Shares in Mach7 Technologies (ASX:M7T) are trading 1.3 per cent higher at $1.21.

Copyright 2020 – Finance News Network

Source: Finance News Network

12FebFebruary 12, 2021

Baby Bunting (ASX:BBN) lifts dividend after profit jumps almost 55%

12 Feb 2021 - Baby Bunting Group (ASX:BBN) saw statutory net profit after tax rise 54.7 per cent to $7.5 million for the half year ended 27 December 2020.

09JunJune 9, 2020

AER releases 5yr regulatory decision for SA Power Networks

05 Jun 2020 - The Australian Energy Regulator (SER) today released its final decision for the next five-year regulatory period for SA Power Networks. Spark Infrastructure Group (ASX:SKI) holds a 49 per cent interest in SA Power Networks.

04JulJuly 4, 2024

Stocks of the Hour: Arafura Rare Earths, Superior Resources, Aeris Resources

04 Jul 2024 - A snapshot of the stocks on the move, featuring Arafura Rare Earths (ASX:ARU), Superior Resources (ASX:SPQ) and Aeris Resources (ASX:AIS).

30DecDecember 30, 2019

AVITA Medical (ASX:AV) secures FDA approval

30 Dec 2019 - AVITA Medical (ASX:AVH, NASDAQ:RECEL) has announced the resignation of joint company secretary Tamara Barr and secured US FDA approval to conduct a feasibility study evaluating the safety and effectiveness of the RECELL® Autologous Cell Harvesting Device for repigmentation of lesions.